344 related articles for article (PubMed ID: 25239657)
1. Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene.
van Blitterswijk M; Mullen B; Wojtas A; Heckman MG; Diehl NN; Baker MC; DeJesus-Hernandez M; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Neumann M; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
Mol Neurodegener; 2014 Sep; 9():38. PubMed ID: 25239657
[TBL] [Abstract][Full Text] [Related]
2. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.
van Blitterswijk M; DeJesus-Hernandez M; Niemantsverdriet E; Murray ME; Heckman MG; Diehl NN; Brown PH; Baker MC; Finch NA; Bauer PO; Serrano G; Beach TG; Josephs KA; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Boylan KB; Petrucelli L; Dickson DW; Rademakers R
Lancet Neurol; 2013 Oct; 12(10):978-88. PubMed ID: 24011653
[TBL] [Abstract][Full Text] [Related]
3. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia.
van Blitterswijk M; Mullen B; Nicholson AM; Bieniek KF; Heckman MG; Baker MC; DeJesus-Hernandez M; Finch NA; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
Acta Neuropathol; 2014 Mar; 127(3):397-406. PubMed ID: 24385136
[TBL] [Abstract][Full Text] [Related]
4. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.
van Blitterswijk M; Mullen B; Heckman MG; Baker MC; DeJesus-Hernandez M; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Neumann M; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
Neurobiol Aging; 2014 Oct; 35(10):2421.e13-7. PubMed ID: 24866401
[TBL] [Abstract][Full Text] [Related]
5. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype.
Rutherford NJ; Heckman MG; Dejesus-Hernandez M; Baker MC; Soto-Ortolaza AI; Rayaprolu S; Stewart H; Finger E; Volkening K; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Knopman DS; Kretzschmar HA; Neumann M; Caselli RJ; White CL; Mackenzie IR; Petersen RC; Strong MJ; Miller BL; Boeve BF; Uitti RJ; Boylan KB; Wszolek ZK; Graff-Radford NR; Dickson DW; Ross OA; Rademakers R
Neurobiol Aging; 2012 Dec; 33(12):2950.e5-7. PubMed ID: 22840558
[TBL] [Abstract][Full Text] [Related]
6. Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.
Davidson YS; Barker H; Robinson AC; Thompson JC; Harris J; Troakes C; Smith B; Al-Saraj S; Shaw C; Rollinson S; Masuda-Suzukake M; Hasegawa M; Pickering-Brown S; Snowden JS; Mann DM
Acta Neuropathol Commun; 2014 Jun; 2():70. PubMed ID: 24950788
[TBL] [Abstract][Full Text] [Related]
7. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
[TBL] [Abstract][Full Text] [Related]
8. The frequency of the C9orf72 expansion in a Brazilian population.
Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W
Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030
[TBL] [Abstract][Full Text] [Related]
9. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers.
Mackenzie IR; Frick P; Grässer FA; Gendron TF; Petrucelli L; Cashman NR; Edbauer D; Kremmer E; Prudlo J; Troost D; Neumann M
Acta Neuropathol; 2015 Dec; 130(6):845-61. PubMed ID: 26374446
[TBL] [Abstract][Full Text] [Related]
11. Screening for C9orf72 Expansion Mutation in Serbian Patients with Early-Onset Dementia.
Mandic-Stojmenovic G; Stefanova E; Dobricic V; Novakovic I; Stojkovic T; Jesic A; Kostic V
Dement Geriatr Cogn Disord; 2015; 40(5-6):358-65. PubMed ID: 26401819
[TBL] [Abstract][Full Text] [Related]
12. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features.
Sha SJ; Takada LT; Rankin KP; Yokoyama JS; Rutherford NJ; Fong JC; Khan B; Karydas A; Baker MC; DeJesus-Hernandez M; Pribadi M; Coppola G; Geschwind DH; Rademakers R; Lee SE; Seeley W; Miller BL; Boxer AL
Neurology; 2012 Sep; 79(10):1002-11. PubMed ID: 22875087
[TBL] [Abstract][Full Text] [Related]
13. Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72.
van Blitterswijk M; Gendron TF; Baker MC; DeJesus-Hernandez M; Finch NA; Brown PH; Daughrity LM; Murray ME; Heckman MG; Jiang J; Lagier-Tourenne C; Edbauer D; Cleveland DW; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Petrucelli L; Boeve BF; Graff-Radford NR; Boylan KB; Dickson DW; Rademakers R
Acta Neuropathol; 2015 Dec; 130(6):863-76. PubMed ID: 26437865
[TBL] [Abstract][Full Text] [Related]
14. Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype.
Katisko K; Huber N; Kokkola T; Hartikainen P; Krüger J; Heikkinen AL; Paananen V; Leinonen V; Korhonen VE; Helisalmi S; Herukka SK; Cantoni V; Gadola Y; Archetti S; Remes AM; Haapasalo A; Borroni B; Solje E
Alzheimers Res Ther; 2022 Oct; 14(1):151. PubMed ID: 36217158
[TBL] [Abstract][Full Text] [Related]
15. Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases.
Hübers A; Marroquin N; Schmoll B; Vielhaber S; Just M; Mayer B; Högel J; Dorst J; Mertens T; Just W; Aulitzky A; Wais V; Ludolph AC; Kubisch C; Weishaupt JH; Volk AE
Neurobiol Aging; 2014 May; 35(5):1214.e1-6. PubMed ID: 24378086
[TBL] [Abstract][Full Text] [Related]
16. C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease.
Harms M; Benitez BA; Cairns N; Cooper B; Cooper P; Mayo K; Carrell D; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; Mayeux R; Chakraverty S; Goate AM; Cruchaga C;
JAMA Neurol; 2013 Jun; 70(6):736-41. PubMed ID: 23588422
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia.
Rosas I; Martínez C; Coto E; Clarimón J; Lleó A; Illán-Gala I; Dols-Icardo O; Borroni B; Almeida MR; van der Zee J; Van Broeckhoven C; ; Bruni AC; Anfossi M; Bernardi L; Maletta R; Serpente M; Galimberti D; Scarpini E; Rossi G; Caroppo P; Benussi L; Ghidoni R; Binetti G; Nacmias B; Sorbi S; Piaceri I; Bagnoli S; Antonell A; Sánchez-Valle R; De la Casa-Fages B; Grandas F; Diez-Fairen M; Pastor P; Ferrari R; ; Queimaliños-Perez D; Pérez-Oliveira S; Álvarez V; Menéndez-González M
Neurobiol Aging; 2021 Mar; 99():99.e15-99.e22. PubMed ID: 32972771
[TBL] [Abstract][Full Text] [Related]
18. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
[TBL] [Abstract][Full Text] [Related]
19. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?
van Blitterswijk M; DeJesus-Hernandez M; Rademakers R
Curr Opin Neurol; 2012 Dec; 25(6):689-700. PubMed ID: 23160421
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion.
Pletnikova O; Sloane KL; Renton AE; Traynor BJ; Crain BJ; Reid T; Zu T; Ranum LP; Troncoso JC; Rabins PV; Onyike CU
Neurobiol Aging; 2014 Oct; 35(10):2419.e17-21. PubMed ID: 24819148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
